{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:20:54Z","timestamp":1787631654503,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-CA225088"],"award-info":[{"award-number":["U54-CA225088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-HL127365"],"award-info":[{"award-number":["U54-HL127365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15POST25230014"],"award-info":[{"award-number":["15POST25230014"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["F32 HL14223"],"award-info":[{"award-number":["F32 HL14223"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["HHSF223201400052C"],"award-info":[{"award-number":["HHSF223201400052C"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Systems"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.cels.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T22:35:57Z","timestamp":1557354957000},"page":"412-426.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming"],"prefix":"10.1016","volume":"8","author":[{"given":"Huan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Everley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Boswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noga","family":"Ron-Harel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison E.","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Holton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison R.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Maliszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia C.","family":"Haigis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Sorger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cels.2019.03.009_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1078155210378913","article-title":"Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice","volume":"17","author":"Agostino","year":"2011","journal-title":"J.\u00a0Oncol. Pharm. Pract."},{"key":"10.1016\/j.cels.2019.03.009_bib2","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.90502.2008","article-title":"VEGF kinase inhibitors: how do they cause hypertension?","volume":"297","author":"Bhargava","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.cels.2019.03.009_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kfw200","article-title":"Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias","volume":"155","author":"Blinova","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cels.2019.03.009_bib4","doi-asserted-by":"crossref","first-page":"e1001666","DOI":"10.1371\/journal.pbio.1001666","article-title":"Hypoxic regulation of Hand1 controls the fetal-neonatal switch in cardiac metabolism","volume":"11","author":"Breckenridge","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cels.2019.03.009_bib5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"Human induced pluripotent stem cell\u2013derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin\u2013induced cardiotoxicity","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCULATIONAHA.108.776831","article-title":"Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics","volume":"118","author":"Chen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cels.2019.03.009_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCRESAHA.109.206920","article-title":"Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics","volume":"106","author":"Cheng","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.cels.2019.03.009_bib9","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cels.2019.03.009_bib10","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cels.2019.03.009_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-61779-885-6_9","article-title":"Relative protein quantification by MS\/MS using the tandem mass tag technology","volume":"893","author":"Dayon","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cels.2019.03.009_bib53","doi-asserted-by":"crossref","first-page":"e02523","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.cels.2019.03.009_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2019.03.009_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.cels.2019.03.009_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12859-016-1433-7","article-title":"KinMap: a web-based tool for interactive navigation through human kinome data","volume":"18","author":"Eid","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cels.2019.03.009_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2013.10.019","article-title":"Cholesterol biosynthesis and ER stress in peroxisome deficiency","volume":"98","author":"Faust","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.cels.2019.03.009_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2106","article-title":"Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition","volume":"7","author":"Force","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cels.2019.03.009_bib16","first-page":"128","article-title":"Reversible cardiotoxicity with tyrosine kinase inhibitors","volume":"8","author":"Francis","year":"2010","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.cels.2019.03.009_bib17","doi-asserted-by":"crossref","first-page":"19111","DOI":"10.1038\/srep19111","article-title":"Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes","volume":"6","author":"Funakoshi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cels.2019.03.009_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12094-016-1508-y","article-title":"Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study","volume":"19","author":"Gavila","year":"2017","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.cels.2019.03.009_bib19","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMoa064320","article-title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","volume":"355","author":"Geyer","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib20","series-title":"Advances in Neural Information Processing Systems 16","first-page":"281","article-title":"Learning the k in k-means","author":"Hamerly","year":"2004"},{"key":"10.1016\/j.cels.2019.03.009_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2184.2008.00549.x","article-title":"Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy","volume":"41","author":"Hinrichsen","year":"2008","journal-title":"Cell Prolif."},{"key":"10.1016\/j.cels.2019.03.009_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.117.305365","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes","volume":"117","author":"Karakikes","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.cels.2019.03.009_bib24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","author":"Kerkel\u00e4","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1752-8062.2008.00090.x","article-title":"Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase","volume":"2","author":"Kerkela","year":"2009","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cels.2019.03.009_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-pharmtox-010617-053110","article-title":"Human induced pluripotent stem cell (hiPSC)-derived cells to assess drug cardiotoxicity: opportunities and problems","volume":"58","author":"Magdy","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cels.2019.03.009_bib27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/jnci\/djn310","article-title":"Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study","volume":"100","author":"Mertens","year":"2008","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.cels.2019.03.009_bib28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cels.2019.03.009_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40169-016-0133-2","article-title":"The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes","volume":"6","author":"Necela","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/HJH.0b013e328326cb04","article-title":"Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure","volume":"27","author":"Ohtani","year":"2009","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.cels.2019.03.009_bib31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/02841860903229124","article-title":"Cardiotoxicity induced by tyrosine kinase inhibitors","volume":"48","author":"Orphanos","year":"2009","journal-title":"Acta Oncol."},{"key":"10.1016\/j.cels.2019.03.009_bib55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expressionanalysis of digital gene expression data","volume":"26","author":"Robinson","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2019.03.009_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.semnephrol.2010.09.007","article-title":"Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker","volume":"30","author":"Robinson","year":"2010","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cels.2019.03.009_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib34","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.2174\/138161208786071317","article-title":"Cardiac metabolism in myocardial ischemia","volume":"14","author":"Rosano","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cels.2019.03.009_bib35","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1200\/JCO.2007.15.6331","article-title":"Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma","volume":"26","author":"Schmidinger","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cels.2019.03.009_bib36","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41467-017-01946-x","article-title":"Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues","volume":"8","author":"Shadrin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cels.2019.03.009_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2584","article-title":"High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells","volume":"9","author":"Sharma","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib38","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1073\/pnas.95.13.7368","article-title":"Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia","volume":"95","author":"Sogawa","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2019.03.009_bib39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1126\/science.aam9305","article-title":"Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass","volume":"358","author":"Spinelli","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cels.2019.03.009_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"Sun","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cels.2019.03.009_bib41","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMc1108849","article-title":"Reversible cardiomyopathy associated with sunitinib and sorafenib","volume":"365","author":"Uraizee","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib42","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K(+) channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cels.2019.03.009_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2003.055095","article-title":"Energy metabolism in heart failure","volume":"555","author":"Ventura-Clapier","year":"2004","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.cels.2019.03.009_bib44","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1152\/physrev.1992.72.4.881","article-title":"Fatty acid homeostasis in the normoxic and ischemic heart","volume":"72","author":"van der Vusse","year":"1992","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cels.2019.03.009_bib46","doi-asserted-by":"crossref","first-page":"e174519","DOI":"10.1001\/jamaoncol.2017.4519","article-title":"Carfilzomib-associated cardiovascular adverse events: a systematic review and meta-analysis","volume":"4","author":"Waxman","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.cels.2019.03.009_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/toxsci\/kfn157","article-title":"Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells","volume":"106","author":"Will","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cels.2019.03.009_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.healun.2009.09.017","article-title":"Reversible regulation of the retinoblastoma protein\/E2F-1 pathway during \u201creverse cardiac remodelling\u201d after ventricular unloading","volume":"29","author":"Wohlschlaeger","year":"2010","journal-title":"J.\u00a0Heart Lung Transplant."},{"key":"10.1016\/j.cels.2019.03.009_bib56","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.cels.2019.03.009_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11010-015-2635-4","article-title":"CDK6 mediates the effect of attenuation of miR-1 on provoking cardiomyocyte hypertrophy","volume":"412","author":"Yuan","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cels.2019.03.009_bib50","doi-asserted-by":"crossref","first-page":"15105","DOI":"10.1074\/jbc.M117.783175","article-title":"Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response","volume":"292","author":"Zhang","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cels.2019.03.009_bib51","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.cels.2019.03.009_bib52","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.celrep.2017.09.005","article-title":"Comparative gene expression analyses reveal distinct molecular signatures between differentially reprogrammed cardiomyocytes","volume":"20","author":"Zhou","year":"2017","journal-title":"Cell Rep."}],"container-title":["Cell Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405471219300791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405471219300791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:39:58Z","timestamp":1778881198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405471219300791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2405471219300791"],"URL":"https:\/\/doi.org\/10.1016\/j.cels.2019.03.009","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/365841","asserted-by":"object"}]},"ISSN":["2405-4712"],"issn-type":[{"value":"2405-4712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming","name":"articletitle","label":"Article Title"},{"value":"Cell Systems","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cels.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}